Autopsy report · NCT00387192

A Study With OPTIVATE® in People With Von Willebrand Disease

“Due to slow recruitment and a significant delay in reaching the recruitment target.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 10 months before it stopped.
• 26 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Bio Products Laboratory

Sponsor type

University, hospital or other

Conditions

Von Willebrand Disease

Interventions

Optivate

Participants

26 (planned, not actual)

Sites

4

Countries

Israel, United Kingdom

Trials that died the same way

• Iloprost for Bridging to Heart Transplantation in PH
  “Delay in recruitment” (83% match in meaning)
• Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
  “slow recruitment.” (82% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.